Disease-Modifying Effects of M(1) Muscarinic Acetylcholine Receptor Activation in an Alzheimer’s Disease Mouse Model

Alzheimer’s disease (AD) is the leading cause of dementia worldwide, and currently no disease-modifying therapy is available to slow or prevent AD, underscoring the urgent need for neuroprotective therapies. Selective M(1) muscarinic acetylcholine receptor (mAChR) activation is an attractive mechani...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:ACS Chem Neurosci
Prif Awduron: Lebois, Evan P., Schroeder, Jason P., Esparza, Thomas J., Bridges, Thomas M., Lindsley, Craig W., Conn, P. Jeffrey, Brody, David L., Daniels, J. Scott, Levey, Allan I.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2017
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5808561/
https://ncbi.nlm.nih.gov/pubmed/28230352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.6b00278
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg